126 related articles for article (PubMed ID: 8707240)
1. [Basedow disease--thyrostatic drugs combined with thyroxine?].
von Werder K
Fortschr Med; 1996 May; 114(14):6-7. PubMed ID: 8707240
[No Abstract] [Full Text] [Related]
2. Is there one successful antithyroid regimen for Graves' disease?
Braverman LE
Lancet; 1996 Sep; 348(9029):697-8. PubMed ID: 8806285
[No Abstract] [Full Text] [Related]
3. A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
Grebe SK; Feek CM; Ford HC; Fagerström JN; Cordwell DP; Delahunt JW; Toomath RJ
Clin Endocrinol (Oxf); 1998 May; 48(5):585-92. PubMed ID: 9666870
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence of Graves-Basedow disease: the influence of treatment schedule].
Goñi Iriarte MJ; Forga Llenas L; Iriarte Beroiz A; Apiñániz EA; Rodríguez Erdozain R; Menéndez Torre E
Med Clin (Barc); 1995 Jan; 104(1):11-4. PubMed ID: 7877347
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia as Harbinger of Graves' Disease: A Rare Presentation.
Paul R; Sarkar R; Roy D; Thakur I; Lahiri G; Sau TJ; Ghosh R
J Assoc Physicians India; 2017 Nov; 65(11):102. PubMed ID: 29322726
[No Abstract] [Full Text] [Related]
6. [Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
Jaffiol C; Baldet L; Ghachem M; Robin M; Mirouze J
Sem Hop; 1973 Feb; 49(10):683-92. PubMed ID: 4122346
[No Abstract] [Full Text] [Related]
7. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
8. [Does antithyroidal drug dose influence relapse of treated Graves-Basedow disease?].
Jover Díaz F; Domínguez Escribano JR
An Med Interna; 2004 May; 21(5):259-60. PubMed ID: 15176936
[No Abstract] [Full Text] [Related]
9. Effect of Addition of Thyroxine in the Treatment of Graves' Disease: A Systematic Review.
Li J; Bai L; Wei F; Wei M; Xiao Y; Yan W; Wei J
Front Endocrinol (Lausanne); 2020; 11():560157. PubMed ID: 33569041
[TBL] [Abstract][Full Text] [Related]
10. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
11. [Drug treatment of immune hyperthyroidism (Basedow disease). Patient selection, long-term follow-up and prevention of recurrence].
Quadbeck B; Hörmann R; Janssen OE; Mann K
Internist (Berl); 2003 Apr; 44(4):440-8. PubMed ID: 12914401
[TBL] [Abstract][Full Text] [Related]
12. [Thyrostatic drug therapy of Basedow disease. Combination with thyroid hormones and/or beta blockers].
Weissel M
Acta Med Austriaca; 1987; 14(3-4):74-6. PubMed ID: 2447739
[TBL] [Abstract][Full Text] [Related]
13. Antithyroid drugs.
Goichot B; Vinzio S
N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15917394
[No Abstract] [Full Text] [Related]
14. Optimizing remission rates using antithyroid drugs for Graves' disease.
Hegedüs L
Clin Endocrinol (Oxf); 2010 Jun; 72(6):729-30. PubMed ID: 20050856
[No Abstract] [Full Text] [Related]
15. [Unclear weight loss. Basedow's disease resp. Graves' disease].
Stettler LB
Praxis (Bern 1994); 2004 Oct; 93(42):1743-4. PubMed ID: 15529962
[No Abstract] [Full Text] [Related]
16. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
17. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
Glaser NS; Styne DM;
Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
[TBL] [Abstract][Full Text] [Related]
18. Thymic hyperplasia and its spontaneous resolution with treatment of Graves' hyperthyroidism.
Shanmugasundaram M; Varadhan L; Katreddy MV; Nayak AU
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27190120
[No Abstract] [Full Text] [Related]
19. [Inorganic and organic phases of radioiodine metabolism in the thyroid in Basedow patients treated with synthetic thyroid antagonists].
Valentini F; Lodeserto A; Reschini E; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):385-95. PubMed ID: 4186148
[No Abstract] [Full Text] [Related]
20. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
